Relationship between the sialic acid content of low-density lipoprotein (LDL) and autoantibodies to oxidized LDL in the plasma of healthy subjects and patients with atherosclerosis

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 1, 2002, Pages 15-20

  Cerne, Darko ^a   Jürgens, Günther ^a   Ledinski, Gerhard ^a   Kager, Gerd ^a   Greiberger, Joachim ^a   Lukac Bajalo, Jana ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Autoantibodies to oxidized LDL; Low density lipoprotein (LDL); Oxidized LDL; Sialic acid

Indexed keywords

AUTOANTIBODY; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SIALIC ACID;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION FUNCTION; HUMAN; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; REGULATORY MECHANISM;

ADULT; ARTERIOSCLEROSIS; AUTOANTIBODIES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID;

EID: 0036188878     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.004     Document Type: Article

References (33)

1. Desialylated low density lipoprotein - Naturally occurring modified lipoprotein with atherogenic potency
2. Multiple modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization
3. Carbohydrate composition of protein and lipid components in sialic-rich and -poor low density lipoproteins from subjects with and without coronary artery disease
4. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells
5. Characteristics of low density lipoprotein subfractions from patients with coronary artery disease
6. Characteristic of low density lipoprotein isolated from circulating immune complexes
7. Sialic acid content of LDL in coronary artery disease: No evidence of desialylation in subjects with coronary stenosis and increased levels in Relation between desialylation and in vitro peroxidation
8. Low-density lipoprotein modification occurring in human plasma. Possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification
9. Natural cryptic autoantibodies
10. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects
11. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent
12. Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: The significance of apolipoprotein B to apolipoprotein all ratio
13. Generation, characterization and histochemical application of monoclonal antibodies selectively recognizing serum lipoproteins
14. ELISA of IgG Antibody to oxidized low density lipoprotein: Effect of blocking buffer and method of data expression
15. Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins
16. Coronary arteriography
17. A comparison of carvedilol and metoprolol antioxidant activities in vitro
18. Effects of two antihypertensive agents, labetalol and metoprolol, on the production of reactive oxygen species by normal polymorphonuclear leukocytes in vitro
19. The effect of beta blocking drugs on lipid peroxidation in rat heart in vitro
20. Oxidized low density lipoprotein - An extreme example of lipoprotein heterogeneity
21. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation
22. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial
23. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
24. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
25. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
26. Intimal medial thickening of common carotid artery as indicator of coronary artery disease
27. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study
28. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
29. Sialic acids and the metabolism of low density lipoprotein
30. Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects. PCVMETRA group
31. LDL sialic acid content in patients with coronary artery disease
32. Sialic acid content of LDL and lipoprotein metabolism in combined hyperlipidemia and primary moderate hypercholesterolemia
33. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease